These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1833347)

  • 1. All calcium channel blockers are not alike.
    Cheng TO
    Int J Cardiol; 1991 Aug; 32(2):267. PubMed ID: 1833347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium antagonists in congestive heart failure].
    Barbieri L; Mestroni L; Camerini F
    G Ital Cardiol; 1988 Nov; 18(11):989-96. PubMed ID: 3073994
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium channel blockers in left ventricular dysfunction or congestive heart failure.
    White CM
    Conn Med; 1997 Oct; 61(10):659-61. PubMed ID: 9375452
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational use of calcium-channel antagonists in Raynaud's phenomenon.
    Sturgill MG; Seibold JR
    Curr Opin Rheumatol; 1998 Nov; 10(6):584-8. PubMed ID: 9812220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of calcium antagonists in the treatment of cardiac insufficiency].
    Moret P
    Ther Umsch; 1984 Feb; 41(2):125-30. PubMed ID: 6369615
    [No Abstract]   [Full Text] [Related]  

  • 6. Evolving role of calcium channel blockers in heart failure.
    Pieper JA
    Pharmacotherapy; 1996; 16(2 Pt 2):43S-49S. PubMed ID: 8668605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
    Massie BM; Lacourcière Y; Viskoper R; Woittiez A; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):27C-33C. PubMed ID: 9286851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse.
    Taylor JM; Simpson RU
    Cancer Res; 1992 May; 52(9):2413-8. PubMed ID: 1533173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Ca2+ channel blockers on arterial hypertension and heart ischaemic lesions induced by chronic blockade of nitric oxide in the rat.
    de Oliveira CF; Nathan LP; Metze K; Moreno H; de Luca IM; Sucupira M; Zatz R; Zappellini A; Antunes E; de Nucci G
    Eur J Pharmacol; 1999 Jun; 373(2-3):195-200. PubMed ID: 10414439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blocking agents in congestive heart failure.
    Baughman KL
    Am J Med; 1986 Feb; 80(2B):46-50. PubMed ID: 3511695
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines.
    de Vries RJ; van Veldhuisen DJ; Dunselman PH
    Am Heart J; 2000 Feb; 139(2 Pt 1):185-94. PubMed ID: 10650289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of amlodipine or nifedipine treatment with developing congestive heart failure: effects on myocyte contractility.
    McElmurray JH; Mukherjee R; Patterson TM; Goldberg A; King MK; Hendrick JW; Gay DM; Clair MJ; Jolly JR; Spinale FG
    J Card Fail; 2001 Jun; 7(2):158-64. PubMed ID: 11420768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium channel blockers in heart failure].
    Hole T; Dickstein K; Gundersen T; Kjekshus J; Myhre ES; Rønnevik PK; Westheim AS
    Tidsskr Nor Laegeforen; 1997 Jun; 117(16):2329-32. PubMed ID: 9265278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of calcium channel antagonists in the amelioration of radial artery vasospasm.
    Bond BR; Zellner JL; Dorman BH; Multani MM; Kratz JM; Crumbley AJ; Crawford FA; Spinale FG
    Ann Thorac Surg; 2000 Apr; 69(4):1035-40; discussion 1040-1. PubMed ID: 10800790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalapril in experimental hypertension and acute heart failure: comparison with calcium channel blockers.
    Sweet CS; Ludden CT; Adkins E; Seymour AA; Emmert S; Ribeiro LG
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S15-9. PubMed ID: 2422487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium-blockers or calcium antagonists].
    Chávez Rivera I
    Arch Inst Cardiol Mex; 1982; 52(3):259-67. PubMed ID: 7052003
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [24-hour protection and control: a new era of calcium antagonists. Amlodipine provides 24 hours of efficacy and safety].
    Med Clin (Barc); 1992 Feb; 98(8):suppl 2 p.. PubMed ID: 1532845
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.
    Lapointe N; Chen H; Qi S; Xu D; Daloze P; Dumont L
    Eur Surg Res; 1999; 31(3):259-66. PubMed ID: 10352354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction.
    Mahé I; Chassany O; Grenard AS; Caulin C; Bergmann JF
    Am J Cardiovasc Drugs; 2003; 3(1):33-41. PubMed ID: 14727944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.